Tobacco smoking, occupation, and p53 nuclear overexpression in early stage bladder cancer

Cancer Epidemiol Biomarkers Prev. 1994 Jan-Feb;3(1):19-24.

Abstract

Epidemiological studies show an increased risk of bladder cancer associated with tobacco smoking and occupational exposures. Certain carcinogens in tobacco and occupational exposures cause DNA damage and may produce specific mutations. TP53 is considered a common target for carcinogenic agents, and mutations of this gene are reported to be the most frequent nuclear abnormalities in human cancer. In order to investigate the relationship between tobacco smoking, occupations, and altered patterns of p53 expression, we have analyzed a group of 109 incident patients with superficial transitional cell carcinoma of the bladder. We assessed p53 nuclear overexpression by the use of anti-p53 antibody PAb1801 and immunohistochemistry, and identified 45 of 109 patients (41%) displaying p53-positive phenotype. We observed a significant association between the number of cigarettes smoked per day and p53 nuclear overexpression (p = 0.02). The odds ratios were 2.3 for those smoking 1-2 packs per day and 8.4 for smoking more than 2 packs per day. Similar estimates were obtained after controlling for age, sex, and race. Elevated odds ratios were also observed for dye-/ink-related (odds ratio = 2.0; 95% CI, 0.4-9.4) and cooking-related occupations (1.8, 0.6-5.0), although those were not statistically significant. These data support the hypothesis that certain carcinogens derived from cigarette smoking and occupations may induce TP53 mutations, which in turn are involved in early steps of bladder carcinogenesis.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Aged
  • Carcinoma, Transitional Cell / chemistry
  • Carcinoma, Transitional Cell / etiology*
  • Carcinoma, Transitional Cell / pathology
  • Chemical Industry*
  • Coloring Agents*
  • Cooking*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Occupational Exposure*
  • Odds Ratio
  • Phenotype
  • Risk Factors
  • Smoking / adverse effects*
  • Tumor Suppressor Protein p53 / analysis*
  • Urinary Bladder Neoplasms / chemistry
  • Urinary Bladder Neoplasms / etiology*
  • Urinary Bladder Neoplasms / pathology

Substances

  • Coloring Agents
  • Tumor Suppressor Protein p53